Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1969 Apr 26;100(16):756–764.

Propranolol in the prophylactic treatment of angina pectoris.

H F Mizgala, A S Khan, R O Davies
PMCID: PMC1945893  PMID: 4888984

Full text

PDF
760

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. APTHORP G. H., CHAMBERLAIN D. A., HAYWARD G. W. THE EFFECTS OF SYMPATHECTOMY ON THE ELECTROCARDIOGRAM AND EFFORT TOLERANCE IN ANGINA PECTORIS. Br Heart J. 1964 Mar;26:218–226. doi: 10.1136/hrt.26.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. ECKSTEIN R. W., STROUD M., 3rd, ECKEL R., DOWLING C. V., PRITCHARD W. H. Effects of control of cardiac work upon coronary flow and O2 consumption after sympathetic nerve stimulation. Am J Physiol. 1950 Dec;163(3):539–544. doi: 10.1152/ajplegacy.1950.163.3.539. [DOI] [PubMed] [Google Scholar]
  3. GILLAM P. M., PRICHARD B. N. USE OF PROPRANOLOL IN ANGINA PECTORIS. Br Med J. 1965 Aug 7;2(5457):337–339. doi: 10.1136/bmj.2.5457.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gianelly R. E., Goldman R. H., Treister B., Harrison D. C. Propranolol in patients with angina pectoris. Ann Intern Med. 1967 Dec;67(6):1216–1225. doi: 10.7326/0003-4819-67-6-1216. [DOI] [PubMed] [Google Scholar]
  5. Gillam P. M., Prichard B. N. Propranolol in the therapy of angina pectoris. Am J Cardiol. 1966 Sep;18(3):366–369. doi: 10.1016/0002-9149(66)90055-5. [DOI] [PubMed] [Google Scholar]
  6. Hebb A. R., Godwin T. F., Gunn R. W. A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris. Can Med Assoc J. 1968 Feb 3;98(5):246–251. [PMC free article] [PubMed] [Google Scholar]
  7. KEELAN P. DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS. Br Med J. 1965 Apr 3;1(5439):897–898. doi: 10.1136/bmj.1.5439.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. MACALPIN R. N., KATTUS A. A., WINFIELD M. E. THE EFFECT OF A BETA-ANDRENERGIC-BLOCKING AGENT (NETHALIDE) AND NITROGLYCERIN ON EXERCISE TOLERANCE IN ANGINA PECTORIS. Circulation. 1965 Jun;31:869–875. doi: 10.1161/01.cir.31.6.869. [DOI] [PubMed] [Google Scholar]
  9. MCNEILL R. S. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS. Lancet. 1964 Nov 21;2(7369):1101–1102. doi: 10.1016/s0140-6736(64)92617-0. [DOI] [PubMed] [Google Scholar]
  10. MYASNIKOV A. L. MYOCARDIAL NECROSES OF CORONARY AND NONCORONARY GENESIS. Am J Cardiol. 1964 Apr;13:435–440. doi: 10.1016/0002-9149(64)90150-x. [DOI] [PubMed] [Google Scholar]
  11. Mendez R., Kabela E. Beta-receptors in coronary vessels. Lancet. 1966 Apr 23;1(7443):907–908. doi: 10.1016/s0140-6736(66)91582-0. [DOI] [PubMed] [Google Scholar]
  12. RONA G., CHAPPEL C. I., BALAZS T., GAUDRY R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. AMA Arch Pathol. 1959 Apr;67(4):443–455. [PubMed] [Google Scholar]
  13. SRIVASTAVA S. C., DEWAR H. A., NEWELL D. J. DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA OF EFFORT. Br Med J. 1964 Sep 19;2(5411):724–725. doi: 10.1136/bmj.2.5411.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shanks R. G. The pharmacology of beta sympathetic blockade. Am J Cardiol. 1966 Sep;18(3):308–316. doi: 10.1016/0002-9149(66)90047-6. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES